1
|
Chatzinikolaou PN, Margaritelis NV, Paschalis V, Theodorou AA, Vrabas IS, Kyparos A, D'Alessandro A, Nikolaidis MG. Erythrocyte metabolism. Acta Physiol (Oxf) 2024; 240:e14081. [PMID: 38270467 DOI: 10.1111/apha.14081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 12/11/2023] [Accepted: 01/01/2024] [Indexed: 01/26/2024]
Abstract
Our aim is to present an updated overview of the erythrocyte metabolism highlighting its richness and complexity. We have manually collected and connected the available biochemical pathways and integrated them into a functional metabolic map. The focus of this map is on the main biochemical pathways consisting of glycolysis, the pentose phosphate pathway, redox metabolism, oxygen metabolism, purine/nucleoside metabolism, and membrane transport. Other recently emerging pathways are also curated, like the methionine salvage pathway, the glyoxalase system, carnitine metabolism, and the lands cycle, as well as remnants of the carboxylic acid metabolism. An additional goal of this review is to present the dynamics of erythrocyte metabolism, providing key numbers used to perform basic quantitative analyses. By synthesizing experimental and computational data, we conclude that glycolysis, pentose phosphate pathway, and redox metabolism are the foundations of erythrocyte metabolism. Additionally, the erythrocyte can sense oxygen levels and oxidative stress adjusting its mechanics, metabolism, and function. In conclusion, fine-tuning of erythrocyte metabolism controls one of the most important biological processes, that is, oxygen loading, transport, and delivery.
Collapse
Affiliation(s)
- Panagiotis N Chatzinikolaou
- Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki, Serres, Greece
| | - Nikos V Margaritelis
- Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki, Serres, Greece
| | - Vassilis Paschalis
- School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Athens, Greece
| | - Anastasios A Theodorou
- Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus
| | - Ioannis S Vrabas
- Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki, Serres, Greece
| | - Antonios Kyparos
- Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki, Serres, Greece
| | - Angelo D'Alessandro
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
| | - Michalis G Nikolaidis
- Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki, Serres, Greece
| |
Collapse
|
2
|
Petkova-Kirova P, Murciano N, Iacono G, Jansen J, Simionato G, Qiao M, Van der Zwaan C, Rotordam MG, John T, Hertz L, Hoogendijk AJ, Becker N, Wagner C, Von Lindern M, Egee S, Van den Akker E, Kaestner L. The Gárdos Channel and Piezo1 Revisited: Comparison between Reticulocytes and Mature Red Blood Cells. Int J Mol Sci 2024; 25:1416. [PMID: 38338693 PMCID: PMC10855361 DOI: 10.3390/ijms25031416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 12/28/2023] [Accepted: 01/03/2024] [Indexed: 02/12/2024] Open
Abstract
The Gárdos channel (KCNN4) and Piezo1 are the best-known ion channels in the red blood cell (RBC) membrane. Nevertheless, the quantitative electrophysiological behavior of RBCs and its heterogeneity are still not completely understood. Here, we use state-of-the-art biochemical methods to probe for the abundance of the channels in RBCs. Furthermore, we utilize automated patch clamp, based on planar chips, to compare the activity of the two channels in reticulocytes and mature RBCs. In addition to this characterization, we performed membrane potential measurements to demonstrate the effect of channel activity and interplay on the RBC properties. Both the Gárdos channel and Piezo1, albeit their average copy number of activatable channels per cell is in the single-digit range, can be detected through transcriptome analysis of reticulocytes. Proteomics analysis of reticulocytes and mature RBCs could only detect Piezo1 but not the Gárdos channel. Furthermore, they can be reliably measured in the whole-cell configuration of the patch clamp method. While for the Gárdos channel, the activity in terms of ion currents is higher in reticulocytes compared to mature RBCs, for Piezo1, the tendency is the opposite. While the interplay between Piezo1 and Gárdos channel cannot be followed using the patch clamp measurements, it could be proved based on membrane potential measurements in populations of intact RBCs. We discuss the Gárdos channel and Piezo1 abundance, interdependencies and interactions in the context of their proposed physiological and pathophysiological functions, which are the passing of small constrictions, e.g., in the spleen, and their active participation in blood clot formation and thrombosis.
Collapse
Affiliation(s)
- Polina Petkova-Kirova
- Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria;
- Department of Biochemistry, Saarland University, 66123 Saarbrücken, Germany
| | - Nicoletta Murciano
- Nanion Technologies, 80339 Munich, Germany; (N.M.); (M.G.R.); (N.B.)
- Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, 66421 Homburg, Germany; (J.J.); (M.Q.); (L.H.)
| | - Giulia Iacono
- Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; (G.I.); (C.V.d.Z.); (A.J.H.); (M.V.L.); (E.V.d.A.)
- Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1007 MB Amsterdam, The Netherlands
| | - Julia Jansen
- Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, 66421 Homburg, Germany; (J.J.); (M.Q.); (L.H.)
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
| | - Greta Simionato
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
- Department of Experimental Surgery, Campus University Hospital, Saarland University, 66421 Homburg, Germany
| | - Min Qiao
- Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, 66421 Homburg, Germany; (J.J.); (M.Q.); (L.H.)
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
| | - Carmen Van der Zwaan
- Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; (G.I.); (C.V.d.Z.); (A.J.H.); (M.V.L.); (E.V.d.A.)
- Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1007 MB Amsterdam, The Netherlands
| | | | - Thomas John
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
| | - Laura Hertz
- Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, 66421 Homburg, Germany; (J.J.); (M.Q.); (L.H.)
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
| | - Arjan J. Hoogendijk
- Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; (G.I.); (C.V.d.Z.); (A.J.H.); (M.V.L.); (E.V.d.A.)
- Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1007 MB Amsterdam, The Netherlands
| | - Nadine Becker
- Nanion Technologies, 80339 Munich, Germany; (N.M.); (M.G.R.); (N.B.)
| | - Christian Wagner
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
- Physics and Materials Science Research Unit, University of Luxembourg, L-1511 Luxembourg, Luxembourg
| | - Marieke Von Lindern
- Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; (G.I.); (C.V.d.Z.); (A.J.H.); (M.V.L.); (E.V.d.A.)
- Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1007 MB Amsterdam, The Netherlands
| | - Stephane Egee
- Biological Station Roscoff, Sorbonne University, CNRS, UMR8227 LBI2M, F-29680 Roscoff, France;
- Laboratory of Excellence GR-Ex, F-75015 Paris, France
| | - Emile Van den Akker
- Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; (G.I.); (C.V.d.Z.); (A.J.H.); (M.V.L.); (E.V.d.A.)
- Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1007 MB Amsterdam, The Netherlands
| | - Lars Kaestner
- Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, 66421 Homburg, Germany; (J.J.); (M.Q.); (L.H.)
- Department of Experimental Physics, Saarland University, 66123 Saarbrücken, Germany (T.J.); (C.W.)
| |
Collapse
|
3
|
Nam YW, Downey M, Rahman MA, Cui M, Zhang M. Channelopathy of small- and intermediate-conductance Ca 2+-activated K + channels. Acta Pharmacol Sin 2023; 44:259-267. [PMID: 35715699 PMCID: PMC9889811 DOI: 10.1038/s41401-022-00935-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2022] [Accepted: 05/31/2022] [Indexed: 02/04/2023] Open
Abstract
Small- and intermediate-conductance Ca2+-activated K+ (KCa2.x/KCa3.1 also called SK/IK) channels are gated exclusively by intracellular Ca2+. The Ca2+ binding protein calmodulin confers sub-micromolar Ca2+ sensitivity to the channel-calmodulin complex. The calmodulin C-lobe is constitutively associated with the proximal C-terminus of the channel. Interactions between calmodulin N-lobe and the channel S4-S5 linker are Ca2+-dependent, which subsequently trigger conformational changes in the channel pore and open the gate. KCNN genes encode four subtypes, including KCNN1 for KCa2.1 (SK1), KCNN2 for KCa2.2 (SK2), KCNN3 for KCa2.3 (SK3), and KCNN4 for KCa3.1 (IK). The three KCa2.x channel subtypes are expressed in the central nervous system and the heart. The KCa3.1 subtype is expressed in the erythrocytes and the lymphocytes, among other peripheral tissues. The impact of dysfunctional KCa2.x/KCa3.1 channels on human health has not been well documented. Human loss-of-function KCa2.2 mutations have been linked with neurodevelopmental disorders. Human gain-of-function mutations that increase the apparent Ca2+ sensitivity of KCa2.3 and KCa3.1 channels have been associated with Zimmermann-Laband syndrome and hereditary xerocytosis, respectively. This review article discusses the physiological significance of KCa2.x/KCa3.1 channels, the pathophysiology of the diseases linked with KCa2.x/KCa3.1 mutations, the structure-function relationship of the mutant KCa2.x/KCa3.1 channels, and potential pharmacological therapeutics for the KCa2.x/KCa3.1 channelopathy.
Collapse
Affiliation(s)
- Young-Woo Nam
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, 92618, USA
| | - Myles Downey
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, 92618, USA
| | - Mohammad Asikur Rahman
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, 92618, USA
| | - Meng Cui
- Department of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, MA, 02115, USA
| | - Miao Zhang
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, 92618, USA.
| |
Collapse
|
4
|
Merlo A, Losserand S, Yaya F, Connes P, Faivre M, Lorthois S, Minetti C, Nader E, Podgorski T, Renoux C, Coupier G, Franceschini E. Influence of storage and buffer composition on the mechanical behavior of flowing red blood cells. Biophys J 2023; 122:360-373. [PMID: 36476993 PMCID: PMC9892622 DOI: 10.1016/j.bpj.2022.12.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 10/17/2022] [Accepted: 12/01/2022] [Indexed: 12/12/2022] Open
Abstract
On-chip study of blood flow has emerged as a powerful tool to assess the contribution of each component of blood to its overall function. Blood has indeed many functions, from gas and nutrient transport to immune response and thermal regulation. Red blood cells play a central role therein, in particular through their specific mechanical properties, which directly influence pressure regulation, oxygen perfusion, or platelet and white cell segregation toward endothelial walls. As the bloom of in-vitro studies has led to the apparition of various storage and sample preparation protocols, we address the question of the robustness of the results involving cell mechanical behavior against this diversity. The effects of three conservation media (EDTA, citrate, and glucose-albumin-sodium-phosphate) and storage time on the red blood cell mechanical behavior are assessed under different flow conditions: cell deformability by ektacytometry, shape recovery of cells flowing out of a microfluidic constriction, and cell-flipping dynamics under shear flow. The impact of buffer solutions (phosphate-buffered saline and density-matched suspension using iodixanol/Optiprep) are also studied by investigating individual cell-flipping dynamics, relative viscosity of cell suspensions, and cell structuration under Poiseuille flow. Our results reveal that storing blood samples up to 7 days after withdrawal and suspending them in adequate density-matched buffer solutions has, in most experiments, a moderate effect on the overall mechanical response, with a possible rapid evolution in the first 3 days after sample collection.
Collapse
Affiliation(s)
- Adlan Merlo
- GDR MECABIO, France; Institut de Mécanique des Fluides de Toulouse (IMFT), Université de Toulouse, CNRS, Toulouse, France; Biomechanics and Bioengineering Laboratory (UMR 7338), Université de Technologie de Compiègne - CNRS, Compiègne, France
| | - Sylvain Losserand
- GDR MECABIO, France; Université Grenoble Alpes, CNRS, LIPhy, Grenoble, France
| | - François Yaya
- GDR MECABIO, France; Université Grenoble Alpes, CNRS, LIPhy, Grenoble, France
| | - Philippe Connes
- GDR MECABIO, France; Team 'Vascular Biology and Red Blood Cell', Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Université Claude Bernard Lyon 1, Université de Lyon, Villeurbanne, France; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France
| | - Magalie Faivre
- GDR MECABIO, France; University Lyon, CNRS, INSA Lyon, Ecole Centrale de Lyon, Université Claude Bernard Lyon 1, CPE Lyon, INL, UMR5270, Villeurbanne, France
| | - Sylvie Lorthois
- GDR MECABIO, France; Institut de Mécanique des Fluides de Toulouse (IMFT), Université de Toulouse, CNRS, Toulouse, France
| | - Christophe Minetti
- Aero Thermo Mechanics CP 165/43, Université libre de Bruxelles, Brussels, Belgium
| | - Elie Nader
- GDR MECABIO, France; Team 'Vascular Biology and Red Blood Cell', Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Université Claude Bernard Lyon 1, Université de Lyon, Villeurbanne, France; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France
| | - Thomas Podgorski
- GDR MECABIO, France; Université Grenoble Alpes, CNRS, LIPhy, Grenoble, France; Université Grenoble Alpes, CNRS, Grenoble INP, LRP, Grenoble, France
| | - Céline Renoux
- GDR MECABIO, France; Team 'Vascular Biology and Red Blood Cell', Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Université Claude Bernard Lyon 1, Université de Lyon, Villeurbanne, France; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France; Service de biochimie et biologie moléculaire, Hospices Civils de Lyon, Lyon, France
| | - Gwennou Coupier
- GDR MECABIO, France; Université Grenoble Alpes, CNRS, LIPhy, Grenoble, France.
| | - Emilie Franceschini
- GDR MECABIO, France; Aix-Marseille University, CNRS, Centrale Marseille, LMA, Turing Center for Living Systems, Marseille, France.
| |
Collapse
|
5
|
Ca 2+-Sensitive Potassium Channels. MOLECULES (BASEL, SWITZERLAND) 2023; 28:molecules28020885. [PMID: 36677942 PMCID: PMC9861210 DOI: 10.3390/molecules28020885] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 01/07/2023] [Accepted: 01/10/2023] [Indexed: 01/18/2023]
Abstract
The Ca2+ ion is used ubiquitously as an intracellular signaling molecule due to its high external and low internal concentration. Many Ca2+-sensing ion channel proteins have evolved to receive and propagate Ca2+ signals. Among them are the Ca2+-activated potassium channels, a large family of potassium channels activated by rises in cytosolic calcium in response to Ca2+ influx via Ca2+-permeable channels that open during the action potential or Ca2+ release from the endoplasmic reticulum. The Ca2+ sensitivity of these channels allows internal Ca2+ to regulate the electrical activity of the cell membrane. Activating these potassium channels controls many physiological processes, from the firing properties of neurons to the control of transmitter release. This review will discuss what is understood about the Ca2+ sensitivity of the two best-studied groups of Ca2+-sensitive potassium channels: large-conductance Ca2+-activated K+ channels, KCa1.1, and small/intermediate-conductance Ca2+-activated K+ channels, KCa2.x/KCa3.1.
Collapse
|
6
|
Allegrini B, Jedele S, David Nguyen L, Mignotet M, Rapetti-Mauss R, Etchebest C, Fenneteau O, Loubat A, Boutet A, Thomas C, Durin J, Petit A, Badens C, Garçon L, Da Costa L, Guizouarn H. New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration. Front Physiol 2022; 13:918620. [PMID: 36003639 PMCID: PMC9393219 DOI: 10.3389/fphys.2022.918620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Accepted: 05/27/2022] [Indexed: 11/13/2022] Open
Abstract
The K+ channel activated by the Ca2+, KCNN4, has been shown to contribute to red blood cell dehydration in the rare hereditary hemolytic anemia, the dehydrated hereditary stomatocytosis. We report two de novo mutations on KCNN4, We reported two de novo mutations on KCNN4, V222L and H340N, characterized at the molecular, cellular and clinical levels. Whereas both mutations were shown to increase the calcium sensitivity of the K+ channel, leading to channel opening for lower calcium concentrations compared to WT KCNN4 channel, there was no obvious red blood cell dehydration in patients carrying one or the other mutation. The clinical phenotype was greatly different between carriers of the mutated gene ranging from severe anemia for one patient to a single episode of anemia for the other patient or no documented sign of anemia for the parents who also carried the mutation. These data compared to already published KCNN4 mutations question the role of KCNN4 gain-of-function mutations in hydration status and viability of red blood cells in bloodstream.
Collapse
Affiliation(s)
- B. Allegrini
- Université Côte d’Azur, CNRS, INSERM, iBV, Nice, France
| | - S. Jedele
- Université Paris Cité and Université des Antilles, Inserm, BIGR, Paris, France
| | - L. David Nguyen
- Université Paris Cité, Paris, France
- AP-HP, Service d’Hématologie Biologique, Hôpital R. Debré, Paris, France
| | - M. Mignotet
- Université Côte d’Azur, CNRS, INSERM, iBV, Nice, France
| | | | - C. Etchebest
- Université Paris Cité and Université des Antilles, Inserm, BIGR, Paris, France
| | - O. Fenneteau
- AP-HP, Service d’Hématologie Biologique, Hôpital R. Debré, Paris, France
| | - A. Loubat
- Université Côte d’Azur, CNRS, INSERM, iBV, Nice, France
| | - A. Boutet
- Hôpital Saint Nazaire, Saint-Nazaire, France
| | - C. Thomas
- CHU Nantes, Service Oncologie-hématologie et Immunologie Pédiatrique, Nantes, France
| | - J. Durin
- Sorbonne Université, AP-HP, Hôpital Armand Trousseau, Service d'Hématologie Oncologie Pédiatrique, Paris, France
| | - A. Petit
- Sorbonne Université, AP-HP, Hôpital Armand Trousseau, Service d'Hématologie Oncologie Pédiatrique, Paris, France
| | - C. Badens
- Aix Marseille Univ, INSERM, MMG, Marseille, France
- AP-HM, Department of Genetic, Marseille, France
| | - L. Garçon
- Université Picardie Jules Verne, Unité EA4666 Hematim, Amiens, France
- CHU Amiens, Service d'Hématologie Biologique, Amiens, France
| | - L. Da Costa
- Université Paris Cité, Paris, France
- AP-HP, Service d’Hématologie Biologique, Hôpital R. Debré, Paris, France
- Université Picardie Jules Verne, Unité EA4666 Hematim, Amiens, France
| | - H. Guizouarn
- Université Côte d’Azur, CNRS, INSERM, iBV, Nice, France
- *Correspondence: H. Guizouarn,
| |
Collapse
|
7
|
Channelopathy-causing mutations in the S 45A/S 45B and HA/HB helices of K Ca2.3 and K Ca3.1 channels alter their apparent Ca 2+ sensitivity. Cell Calcium 2022; 102:102538. [PMID: 35030515 PMCID: PMC8844225 DOI: 10.1016/j.ceca.2022.102538] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 01/05/2022] [Accepted: 01/06/2022] [Indexed: 12/11/2022]
Abstract
Small- and intermediate-conductance Ca2+-activated potassium (KCa2.x and KCa3.1, also called SK and IK) channels are activated exclusively by a Ca2+-calmodulin gating mechanism. Wild-type KCa2.3 channels have a Ca2+ EC50 value of ∼0.3 μM, while the apparent Ca2+ sensitivity of wild-type KCa3.1 channels is ∼0.27 μM. Heterozygous genetic mutations of KCa2.3 channels have been associated with Zimmermann-Laband syndrome and idiopathic noncirrhotic portal hypertension, while KCa3.1 channel mutations were reported in hereditary xerocytosis patients. KCa2.3_S436C and KCa2.3_V450L channels with mutations in the S45A/S45B helices exhibited hypersensitivity to Ca2+. The corresponding mutations in KCa3.1 channels also elevated the apparent Ca2+ sensitivity. KCa3.1_S314P, KCa3.1_A322V and KCa3.1_R352H channels with mutations in the HA/HB helices are hypersensitive to Ca2+, whereas KCa2.3 channels with the equivalent mutations are not. The different effects of the equivalent mutations in the HA/HB helices on the apparent Ca2+ sensitivity of KCa2.3 and KCa3.1 channels may imply distinct modulation of the two channel subtypes by the HA/HB helices. AP14145 reduced the apparent Ca2+ sensitivity of the hypersensitive mutant KCa2.3 channels, suggesting the potential therapeutic usefulness of negative gating modulators.
Collapse
|
8
|
von Lindern M, Egée S, Bianchi P, Kaestner L. The Function of Ion Channels and Membrane Potential in Red Blood Cells: Toward a Systematic Analysis of the Erythroid Channelome. Front Physiol 2022; 13:824478. [PMID: 35177994 PMCID: PMC8844196 DOI: 10.3389/fphys.2022.824478] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 01/04/2022] [Indexed: 01/14/2023] Open
Abstract
Erythrocytes represent at least 60% of all cells in the human body. During circulation, they experience a huge variety of physical and chemical stimulations, such as pressure, shear stress, hormones or osmolarity changes. These signals are translated into cellular responses through ion channels that modulate erythrocyte function. Ion channels in erythrocytes are only recently recognized as utmost important players in physiology and pathophysiology. Despite this awareness, their signaling, interactions and concerted regulation, such as the generation and effects of “pseudo action potentials”, remain elusive. We propose a systematic, conjoined approach using molecular biology, in vitro erythropoiesis, state-of-the-art electrophysiological techniques, and channelopathy patient samples to decipher the role of ion channel functions in health and disease. We need to overcome challenges such as the heterogeneity of the cell population (120 days lifespan without protein renewal) or the access to large cohorts of patients. Thereto we will use genetic manipulation of progenitors, cell differentiation into erythrocytes, and statistically efficient electrophysiological recordings of ion channel activity.
Collapse
Affiliation(s)
- Marieke von Lindern
- Sanquin Research and Landsteiner Laboratory, Department of Hematopoiesis, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
- Department of Cell Biology and Genetics, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Stéphane Egée
- Integrative Biology of Marine Models, Station Biologique de Roscoff, CNRS, UMR 8227, Sorbonne Université, Roscoff Cedex, France
- Laboratoire d’Excellence GR-Ex, Paris, France
| | - Paola Bianchi
- Pathophysiology of Anemia Unit, Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
| | - Lars Kaestner
- Theoretical Medicine and Biosciences, Medical Faculty, Saarland University, Homburg, Germany
- Dynamics of Fluids, Experimental Physics, Saarland University, Saarbrücken, Germany
- *Correspondence: Lars Kaestner,
| |
Collapse
|
9
|
Immanuel T, Li J, Green TN, Bogdanova A, Kalev-Zylinska ML. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential. Front Oncol 2022; 12:1010506. [PMID: 36330491 PMCID: PMC9623116 DOI: 10.3389/fonc.2022.1010506] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Accepted: 09/21/2022] [Indexed: 02/05/2023] Open
Abstract
Intracellular calcium signaling regulates diverse physiological and pathological processes. In solid tumors, changes to calcium channels and effectors via mutations or changes in expression affect all cancer hallmarks. Such changes often disrupt transport of calcium ions (Ca2+) in the endoplasmic reticulum (ER) or mitochondria, impacting apoptosis. Evidence rapidly accumulates that this is similar in blood cancer. Principles of intracellular Ca2+ signaling are outlined in the introduction. We describe different Ca2+-toolkit components and summarize the unique relationship between extracellular Ca2+ in the endosteal niche and hematopoietic stem cells. The foundational data on Ca2+ homeostasis in red blood cells is discussed, with the demonstration of changes in red blood cell disorders. This leads to the role of Ca2+ in neoplastic erythropoiesis. Then we expand onto the neoplastic impact of deregulated plasma membrane Ca2+ channels, ER Ca2+ channels, Ca2+ pumps and exchangers, as well as Ca2+ sensor and effector proteins across all types of hematologic neoplasms. This includes an overview of genetic variants in the Ca2+-toolkit encoding genes in lymphoid and myeloid cancers as recorded in publically available cancer databases. The data we compiled demonstrate that multiple Ca2+ homeostatic mechanisms and Ca2+ responsive pathways are altered in hematologic cancers. Some of these alterations may have genetic basis but this requires further investigation. Most changes in the Ca2+-toolkit do not appear to define/associate with specific disease entities but may influence disease grade, prognosis, treatment response, and certain complications. Further elucidation of the underlying mechanisms may lead to novel treatments, with the aim to tailor drugs to different patterns of deregulation. To our knowledge this is the first review of its type in the published literature. We hope that the evidence we compiled increases awareness of the calcium signaling deregulation in hematologic neoplasms and triggers more clinical studies to help advance this field.
Collapse
Affiliation(s)
- Tracey Immanuel
- Blood and Cancer Biology Laboratory, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
| | - Jixia Li
- Blood and Cancer Biology Laboratory, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
- Department of Laboratory Medicine, School of Medicine, Foshan University, Foshan City, China
| | - Taryn N. Green
- Blood and Cancer Biology Laboratory, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
| | - Anna Bogdanova
- Red Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zürich, Switzerland
- Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland
| | - Maggie L. Kalev-Zylinska
- Blood and Cancer Biology Laboratory, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
- Haematology Laboratory, Department of Pathology and Laboratory Medicine, Auckland City Hospital, Auckland, New Zealand
- *Correspondence: Maggie L. Kalev-Zylinska,
| |
Collapse
|
10
|
Buks R, Dagher T, Rotordam MG, Monedero Alonso D, Cochet S, Gautier EF, Chafey P, Cassinat B, Kiladjian JJ, Becker N, Plo I, Egée S, El Nemer W. Altered Ca 2+ Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal Erythropoiesis. Cells 2021; 11:49. [PMID: 35011611 PMCID: PMC8750512 DOI: 10.3390/cells11010049] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2021] [Revised: 12/20/2021] [Accepted: 12/21/2021] [Indexed: 02/07/2023] Open
Abstract
Over 95% of Polycythemia Vera (PV) patients carry the V617F mutation in the tyrosine kinase Janus kinase 2 (JAK2), resulting in uncontrolled erythroid proliferation and a high risk of thrombosis. Using mass spectrometry, we analyzed the RBC membrane proteome and showed elevated levels of multiple Ca2+ binding proteins as well as endoplasmic-reticulum-residing proteins in PV RBC membranes compared with RBC membranes from healthy individuals. In this study, we investigated the impact of JAK2V617F on (1) calcium homeostasis and RBC ion channel activity and (2) protein expression and sorting during terminal erythroid differentiation. Our data from automated patch-clamp show modified calcium homeostasis in PV RBCs and cell lines expressing JAK2V617F, with a functional impact on the activity of the Gárdos channel that could contribute to cellular dehydration. We show that JAK2V617F could play a role in organelle retention during the enucleation step of erythroid differentiation, resulting in modified whole cell proteome in reticulocytes and RBCs in PV patients. Given the central role that calcium plays in the regulation of signaling pathways, our study opens new perspectives to exploring the relationship between JAK2V617F, calcium homeostasis, and cellular abnormalities in myeloproliferative neoplasms, including cellular interactions in the bloodstream in relation to thrombotic events.
Collapse
Affiliation(s)
- Ralfs Buks
- BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France; (R.B.); (S.C.)
- Institut National de la Transfusion Sanguine, F-75015 Paris, France
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
| | - Tracy Dagher
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- U1287, Inserm, Université Paris-Saclay, Gustave Roussy, F-94800 Villejuif, France
| | - Maria Giustina Rotordam
- Nanion Technologies GmbH, 80339 Munich, Germany; (M.G.R.); (N.B.)
- Theoretical Medicine and Biosciences, Medical Faculty, Saarland University, Kirrbergerstr. 100, DE-66424 Homburg, Germany
| | - David Monedero Alonso
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- Sorbonne Université, CNRS, UMR LBI2M, Station Biologique de Roscoff SBR, F-29680 Roscoff, France
| | - Sylvie Cochet
- BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France; (R.B.); (S.C.)
- Institut National de la Transfusion Sanguine, F-75015 Paris, France
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
| | - Emilie-Fleur Gautier
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- Institut Imagine-INSERM U1163, Necker Hospital, Université de Paris, F-75015 Paris, France
- Proteomics Platform 3P5, Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104 Paris, France;
| | - Philippe Chafey
- Proteomics Platform 3P5, Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104 Paris, France;
| | - Bruno Cassinat
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- IRSL, U1131, INSERM, Université de Paris, F-75010 Paris, France
- Hôpital Saint-Louis, Laboratoire de Biologie Cellulaire, AP-HP, F-75010 Paris, France
| | - Jean-Jacques Kiladjian
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- IRSL, U1131, INSERM, Université de Paris, F-75010 Paris, France
- Centre d’Investigations Cliniques, Hôpital Saint-Louis, Université de Paris, F-75010 Paris, France
| | - Nadine Becker
- Nanion Technologies GmbH, 80339 Munich, Germany; (M.G.R.); (N.B.)
| | - Isabelle Plo
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- U1287, Inserm, Université Paris-Saclay, Gustave Roussy, F-94800 Villejuif, France
| | - Stéphane Egée
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- Sorbonne Université, CNRS, UMR LBI2M, Station Biologique de Roscoff SBR, F-29680 Roscoff, France
| | - Wassim El Nemer
- BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France; (R.B.); (S.C.)
- Institut National de la Transfusion Sanguine, F-75015 Paris, France
- Laboratoire d’Excellence GR-Ex, F-75015 Paris, France; (T.D.); (D.M.A.); (E.-F.G.); (B.C.); (J.-J.K.); (I.P.); (S.E.)
- Etablissement Français du Sang PACA-Corse, F-13005Marseille, France
- Aix Marseille Univ, EFS, CNRS, ADES, “Biologie des Groupes Sanguins”, F-13005 Marseille, France
| |
Collapse
|
11
|
Mechanistic ion channel interactions in red cells of patients with Gárdos channelopathy. Blood Adv 2021; 5:3303-3308. [PMID: 34468723 DOI: 10.1182/bloodadvances.2020003823] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 04/07/2021] [Indexed: 12/25/2022] Open
Abstract
In patients with Gárdos channelopathy (p.R352H), an increased concentration of intracellular Ca2+ was previously reported. This is a surprising finding because the Gárdos channel (KCa3.1) is a K+ channel. Here, we confirm the increased intracellular Ca2+ for patients with the KCa3.1 mutation p.S314P. Furthermore, we provide the concept of KCa3.1 activity resulting in a flickering of red blood cell (RBC) membranepotential, which activates the CaV2.1 channel allowing Ca2+ to enter the RBC. Activity of the nonselective cation channel Piezo1 modulates the aforementioned interplay in away that a closed Piezo1 is in favor of the KCa3.1-CaV2.1 interaction. In contrast, Piezo1 openings compromise the membrane potential flickering, thus limiting the activity of CaV2.1. With the compound NS309, we mimic a gain-of-function mutation of KCa3.1. Assessing the RBC Ca2+ response by Fluo-4-based flow cytometry and by measuring the membrane potential using the Macey-Bennekou-Egée method, we provide data that support the concept of the KCa3.1/CaV2.1/Piezo1 interplay as a partial explanation for an increased number of high Ca2+ RBCs. With the pharmacological inhibition of KCa3.1 (TRAM34 and Senicapoc), CaV2.1 (ω-agatoxin TK), and Piezo1 (GsMTx-4), we could project the NS309 behavior of healthy RBCs to the RBCs of Gárdos channelopathy patients.
Collapse
|
12
|
Mansour‐Hendili L, Egée S, Monedero‐Alonso D, Bouyer G, Godeau B, Badaoui B, Lunati A, Noizat C, Aissat A, Kiger L, Mekki C, Picard V, Moutereau S, Fanen P, Bartolucci P, Garçon L, Galactéros F, Funalot B. Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation. Am J Hematol 2021; 96:E318-E321. [PMID: 34004026 DOI: 10.1002/ajh.26245] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Revised: 05/14/2021] [Accepted: 05/14/2021] [Indexed: 11/10/2022]
Affiliation(s)
- Lamisse Mansour‐Hendili
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex Université Paris Est Créteil 61 Avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Stéphane Egée
- CNRS, Integrative Biology of Marine Models Sorbonne Université Place Georges Teissier Roscoff Finistère 29680 France
- Laboratoire d'Excellence GR‐Ex Laboratoire d'Excellence GR‐Ex 24, Boulevard du Montparnasse Paris ile‐de‐France 75015 France
| | - David Monedero‐Alonso
- CNRS, Integrative Biology of Marine Models Sorbonne Université Place Georges Teissier Roscoff Finistère 29680 France
- Laboratoire d'Excellence GR‐Ex Laboratoire d'Excellence GR‐Ex 24, Boulevard du Montparnasse Paris ile‐de‐France 75015 France
| | - Guillaume Bouyer
- CNRS, Integrative Biology of Marine Models Sorbonne Université Place Georges Teissier Roscoff Finistère 29680 France
- Laboratoire d'Excellence GR‐Ex Laboratoire d'Excellence GR‐Ex 24, Boulevard du Montparnasse Paris ile‐de‐France 75015 France
| | - Bertrand Godeau
- Département de médecine interne AP‐HP, Hôpitaux Universitaires Henri Mondor 51 avenue du MAréchal de Lattre de Tassigny Créteil Val‐de‐Marne 94010 France
- INSERM, IMRB Université Paris Est Créteil 61 avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Bouchra Badaoui
- Département d'hématologie et d'immunologie AP‐HP, Hôpitaux Universitaires Henri Mondor 51 avenue du Maréchal de Lattre de Tassigny Créteil Val‐de‐Marne 94010 France
| | - Ariane Lunati
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- INSERM, IMRB Université Paris Est Créteil 61 avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Clara Noizat
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
| | - Abdelrazak Aissat
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- INSERM, IMRB Université Paris Est Créteil 61 avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Laurent Kiger
- IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex Université Paris Est Créteil 61 Avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Chadia Mekki
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
| | - Véronique Picard
- Département d'hématologie biologique AP‐HP, Hôpital Bicêtre 78 Rue du Général Leclerc Le Kremlin‐Bicêtre Val‐de‐MArne 94270 France
| | - Stéphane Moutereau
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex Université Paris Est Créteil 61 Avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Pascale Fanen
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- INSERM, IMRB Université Paris Est Créteil 61 avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| | - Pablo Bartolucci
- IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex Université Paris Est Créteil 61 Avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
- Red Cell Disease Referral Center – UMGGR AP‐HP, Hôpitaux Universitaires Henri Mondor 51 avenue du Maréchal de Lattre de Tassigny Créteil Val‐de‐Marne 94010 France
| | - Loïc Garçon
- Laboratoire Hématopoïèse et Immunologie (HEMATIM) EA4666 Université Picardie Jules Verne 51 Boulevard de Châteaudun Amiens Hauts‐de‐France 80000 France
- Service d'Hématologie Biologique CHU d'Amiens 1 rond‐point du Professeur Christian Cabrol Amiens Hauts‐de‐France 80000 France
- Service de Génétique Constitutionnelle CHU d'Amiens 1 rond‐point du Professeur Christian Cabrol Amiens Hauts‐de‐France 80000 France
| | - Frédéric Galactéros
- IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex Université Paris Est Créteil 61 Avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
- Red Cell Disease Referral Center – UMGGR AP‐HP, Hôpitaux Universitaires Henri Mondor 51 avenue du Maréchal de Lattre de Tassigny Créteil Val‐de‐Marne 94010 France
| | - Benoît Funalot
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale, AP‐HP Hôpitaux Universitaires Henri Mondor 51 Avenue du Maréchal de Lattre de Tassigny Créteil Val‐deMarne France
- INSERM, IMRB Université Paris Est Créteil 61 avenue du Général de Gaulle Créteil Val‐de‐Marne 94000 France
| |
Collapse
|
13
|
Simionato G, van Wijk R, Quint S, Wagner C, Bianchi P, Kaestner L. Rare Anemias: Are Their Names Just Smoke and Mirrors? Front Physiol 2021; 12:690604. [PMID: 34177628 PMCID: PMC8222994 DOI: 10.3389/fphys.2021.690604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2021] [Accepted: 05/17/2021] [Indexed: 12/03/2022] Open
Affiliation(s)
- Greta Simionato
- Institute for Clinical and Experimental Surgery, Campus University Hospital, Saarland University, Homburg, Germany.,Experimental Physics, Dynamics of Fluids Group, Saarland University, Saarbrücken, Germany
| | - Richard van Wijk
- Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
| | - Stephan Quint
- Experimental Physics, Dynamics of Fluids Group, Saarland University, Saarbrücken, Germany.,Cysmic GmbH, Saarbrücken, Germany
| | - Christian Wagner
- Experimental Physics, Dynamics of Fluids Group, Saarland University, Saarbrücken, Germany.,Physics and Materials Science Research Unit, University of Luxembourg, Luxembourg, Luxembourg
| | - Paola Bianchi
- Fondazione Instituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico Milano, Unità Operativa Complessa Ematologia, Unità Operativa Semplice Fisiopatologia delle Anemie, Milan, Italy
| | - Lars Kaestner
- Experimental Physics, Dynamics of Fluids Group, Saarland University, Saarbrücken, Germany.,Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University, Homburg, Germany
| |
Collapse
|
14
|
Fermo E, Vercellati C, Marcello AP, Keskin EY, Perrotta S, Zaninoni A, Brancaleoni V, Zanella A, Giannotta JA, Barcellini W, Bianchi P. Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study. Front Physiol 2021; 12:684569. [PMID: 34093240 PMCID: PMC8176228 DOI: 10.3389/fphys.2021.684569] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Accepted: 04/27/2021] [Indexed: 01/01/2023] Open
Abstract
Congenital hemolytic anemias (CHAs) are heterogeneous and rare disorders caused by alterations in structure, membrane transport, metabolism, or red blood cell production. The pathophysiology of these diseases, in particular the rarest, is often poorly understood, and easy-to-apply tools for diagnosis, clinical management, and patient stratification are still lacking. We report the 3-years monocentric experience with a 43 genes targeted Next Generation Sequencing (t-NGS) panel in diagnosis of CHAs; 122 patients from 105 unrelated families were investigated and the results compared with conventional laboratory pathway. Patients were divided in two groups: 1) cases diagnosed with hematologic investigations to be confirmed at molecular level, and 2) patients with unexplained anemia after extensive hematologic investigation. The overall sensitivity of t-NGS was 74 and 35% for families of groups 1 and 2, respectively. Inside this cohort of patients we identified 26 new pathogenic variants confirmed by functional evidence. The implementation of laboratory work-up with t-NGS increased the number of diagnoses in cases with unexplained anemia; cytoskeleton defects are well detected by conventional tools, deserving t-NGS to atypical cases; the diagnosis of Gardos channelopathy, some enzyme deficiencies, familial siterosterolemia, X-linked defects in females and other rare and ultra-rare diseases definitely benefits of t-NGS approaches.
Collapse
Affiliation(s)
- Elisa Fermo
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Cristina Vercellati
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Anna Paola Marcello
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Ebru Yilmaz Keskin
- Department of Pediatric Hematology and Oncology, Suleyman Demirel University, Isparta, Turkey
| | - Silverio Perrotta
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania "Luigi Vanvitelli," Naples, Italy
| | - Anna Zaninoni
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Valentina Brancaleoni
- UOC Medicina Generale, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Alberto Zanella
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Juri A Giannotta
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Wilma Barcellini
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Paola Bianchi
- UOS Fisiopatologia delle Anemie, UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| |
Collapse
|
15
|
Pérès L, Monedero Alonso D, Nudel M, Figeac M, Bruge J, Sebda S, Picard V, El Nemer W, Preudhomme C, Rose C, Egée S, Bouyer G. Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype. Br J Haematol 2021; 194:e51-e55. [PMID: 33973227 DOI: 10.1111/bjh.17467] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Laurent Pérès
- Sorbonne Université, CNRS, UMR8227, Station Biologique de Roscoff, Roscoff, France.,Laboratoire d'Excellence GR-Ex, Paris, France
| | - David Monedero Alonso
- Sorbonne Université, CNRS, UMR8227, Station Biologique de Roscoff, Roscoff, France.,Laboratoire d'Excellence GR-Ex, Paris, France
| | - Morgane Nudel
- Hôpital Saint Vincent de Paul, Université Catholique, Lille, France
| | - Martin Figeac
- Univ-Lille, Plate-forme de Génomique Fonctionnelle et Structurale, Lille, France.,CHU Lille, cellule bioinformatique, plateau commun de séquençage, Lille, France
| | - Judith Bruge
- Hôpital Saint Vincent de Paul, Université Catholique, Lille, France
| | - Shéhérazade Sebda
- Univ-Lille, Plate-forme de Génomique Fonctionnelle et Structurale, Lille, France
| | | | - Wassim El Nemer
- Inserm, UMR_S 1134, Institut National de la Transfusion Sanguine INTS, Paris, France.,Laboratoire d'Excellence GR-Ex, Paris, France
| | - Claude Preudhomme
- Univ-Lille, Plate-forme de Génomique Fonctionnelle et Structurale, Lille, France
| | - Christian Rose
- Hôpital Saint Vincent de Paul, Université Catholique, Lille, France
| | - Stéphane Egée
- Sorbonne Université, CNRS, UMR8227, Station Biologique de Roscoff, Roscoff, France.,Laboratoire d'Excellence GR-Ex, Paris, France
| | - Guillaume Bouyer
- Sorbonne Université, CNRS, UMR8227, Station Biologique de Roscoff, Roscoff, France.,Laboratoire d'Excellence GR-Ex, Paris, France
| |
Collapse
|